ENTITY
Ambio Pharmaceuticals

Ambio Pharmaceuticals (ABP HK)

3
Analysis
Health CareHong Kong

29 Aug 2021 09:38

ECM Weekly (29th August 2021) - Imeik, Helen’s, Jenscare, Dingdang, Simplex, Hyundai Heavy

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
25 Aug 2021 08:42

AmbioPharm (昂博制药) Pre-IPO: Peptide CDMO Leader Turning Licensor

AmbioPharm is a global leader in the peptide CDMO business and will further monetizing its expertise by collaborating with partners to develop...

Logo
821 Views
Share
12 Aug 2021 09:23

Pre-IPO Ambio Pharmaceuticals - The Particularity of Peptide Drugs, the Strength and the Concerns

The article mainly analyzed Ambio Pharmaceuticals in terms of the particularity of peptide drugs & industry characteristics, the strength of its...

Logo
526 Views
Share
No more insights
x